研究業績

  • トップ
  •  › 
  • 臨床実績・研究業績
  •  › 
  • 研究業績

研究業績

・ Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma
Uchimoto T, Fukushima T, Komura K, Fukuokaya W, Adachi T, Hashimoto T, Yoshizawa A, Nakamura K, Yano Y, Nishimura K, Nishio K, Nakamori K, Iwatani K, Yamamoto S, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Kimura T, Ohno Y, Shiroki R, Egawa S, Azuma H.
BJU Int. 2023 Apr;131(4):477-485.
PMID：36098556
・ Clinical value of minimum apparent diffusion coefficient for prediction of clinically significant prostate cancer in the transition zone
Ono A, Hashimoto T, Shishido T, Hirasawa Y, Satake N, Namiki K, Saito K, Ohno Y.
Int J Clin Oncol. 2023 May;28(5):716-723.
PMID：36961616
・ Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features
Matsubara S, Saito A, Tokuyama N, Muraoka R, Hashimoto T, Satake N, Nagao T, Kuroda M, Ohno Y.
Sci Rep. 2023 Jul 7;13(1):11035.
PMID：37419897
・ Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer
Tsujino T, Tokushige S, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Ohno T, Nakamori K, Maenosono R, Nishimura K, Yamazaki S, Uchimoto T, Yanagisawa T, Mori K, Urabe F, Tsuzuki S, Iwatani K, Yamamoto S, Takahara K, Inamoto T, Kimura T, Ohno Y, Shiroki R, Azuma H.
Cancer Med. 2023 Oct;12(19):19414-19422.
PMID：37706578
・ Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases
Nishio K, Higashio T, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Tsuchida S, Matsuda T, Tsujino T, Nishimura K, Tokushige S, Nakamori K, Uchimoto T, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Kimura T, Ohno Y, Shiroki R, Azuma H.
Oncology. 2023 Oct 13.
PMID：37839399
・ Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study
Nukaya T, Takahara K, Yoshizawa A, Saruta M, Yano Y, Ohno T, Uchimoto T, Fukuokaya W, Adachi T, Yamazaki S, Tokushige S, Nishimura K, Tsujino T, Nakamori K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Hirasawa Y, Hashimoto T, Komura K, Inamoto T, Miki J, Kimura T, Ohno Y, Azuma H, Shiroki R.
Clin Genitourin Cancer. 2023 Oct 1:S1558-7673(23)00219-7.
PMID：37880020
・ Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma
Tsujino T, Komura K, Inamoto T, Maenosono R, Hashimoto T, Adachi T, Hirasawa Y, Tokushige S, Ohno T, Yamazaki S, Fukushima T, Nakamura K, Yano Y, Nishimura K, Kinoshita S, Nakamori K, Tsutsumi T, Matsunaga T, Yoshikawa Y, Uchimoto T, Takai T, Minami K, Uehara H, Hirano H, Nomi H, Takahara K, Ohno Y, Azuma H.
World J Urol. 2023 Dec;41(12):3585-3591.
PMID：37924336
・ Comparison of Postoperative Stress Urinary Incontinence between Anteroposterior Dissection and Modified Gilling Method in Holmium Laser Enucleation of the Prostate
Shishido T, Hirasawa Y, Kashima T, Hashimoto T, Satake N, Hayashi K, Aizawa T, Harada K, Taguri M, Ohno Y.
Urol J. 2023 Oct 29.
PMID：37990797
・ Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study
Fukuokaya W, Koike Y, Yata Y, Komura K, Uchimoto T, Tsujino T, Saruta M, Takahara K, Fujita K, Minami T, Adachi T, Hirasawa Y, Hashimoto T, Ohno Y, Uemura H, Shiroki R, Azuma H, Kimura T.
Int J Urol. 2023 Dec 19.
PMID：38113343

・ Prostate-specific antigen nomogram to predict advanced prostate cancer using area under the receiver operating characteristic curve boosting
Hashimoto T, Komori O, Nakashima J, Kashima T, Yamaguchi Y, Satake N, Nakagami Y, Shishido T, Namiki K, Ohno Y.
Urol Oncol. 2022 Apr;40(4):162.e9-162.e16.
PMID：35065881
・ Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features.
Tokuyama N, Saito A, Muraoka R, Matsubara S, Hashimoto T, Satake N, Matsubayashi J, Nagao T, Mirza AH, Graf HP, Cosatto E, Wu CL, Kuroda M, Ohno Y.
Mod Pathol. 2022 Apr;35(4):533-538.
PMID：34716417
・ Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival
Keita Nakamori , Shogo Yamazaki , Kazumasa Komura , Wataru Fukuokaya , Takahiro Adachi , Yosuke Hirasawa, Takeshi Hashimoto , Atsuhiko Yoshizawa, Takaya Ohno, Yusuke Yano, Kazuki Nishimura, Satoshi Tokushige, Taizo Uchimoto, Shutaro Yamamoto, Kosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, Takafumi Yanagisawa, Shunsuke Tsuduki, Kiyoshi Takahara, Teruo Inamoto, Jun Miki, Takahiro Kimura, Yoshio Ohno, Ryoichi Shiroki, Haruhito Azuma
Clin Transl Radiat Oncol. 2022 Dec 10:39:100558.
PMID：36545361
・ Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab
Yano Y, Ohno T, Komura K, Fukuokaya W, Uchimoto T, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Yamazaki S, Tokushige S, Nishimura K, Tsujino T, Nakamori K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Kimura T, Ohno Y, Shiroki R, Azuma H.
Cancers (Basel). 2022 Nov 17;14(22):5659.
PMID：36428750

・ Diagnostic performance of OncuriaTM, a urinalysis test for bladder cancer
Hirasawa Y, Pagano I, Chen R, Sun Y, Dai Y, Gupta A, Tikhonenkov S, Goodison S, Rosser CJ, Furuya H.
J Transl Med. 2021 Apr 6;19(1):141.
PMID：33823873
・ Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate Cancer
Hirasawa Y, Pagano I, Huang J, Sasaki Y, Murakami K, Rosser CJ, Furuya H.
Hawaii J Health Soc Welf. 2021 Oct;80(10):242-250.
PMID：34661119
・ HoLEP, モーセレーション時の灌流効率の検討
宍戸 俊英, 石田 卓也, 橋本 剛, 佐竹 直哉, 並木 一典, 相澤 卓, 林 建二郎, 大野 芳正
Japanese Journal of Endourology 2021年 34 巻 2 号 350-355

・ Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy.
Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y.
Urol J. 2020 Jan 26;17(1):42-49
PMID：30882158
・ The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.
Hashimoto T, Nakashima J, Inoue R, Komori O, Yamaguchi Y, Kashima T, Satake N, Nakagami Y, Namiki K, Nagao T, Ohno Y
Int J Clin Oncol. 2020 Feb;25(2):377-383.
PMID：31673831
・ Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy
Hashimoto T, Nakashima J, Kashima T, Yamaguchi Y, Satake N, Nakagami Y, Namiki K, Ohno Y
Int J Clin Oncol. 2020 Sep;25(9):1704-1710
PMID：32500468
・ Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort
Matsunaga T, Komura K, Hashimoto T, Muraoka R, Satake N, Tsutsumi T, Tsujino T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.
World J Urol. 2020 Dec;38(12):3183-3190.
PMID：32065276
・ Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ～data from a multi-institutional study in Japan～
Tsutsumi T, Komura K, Hashimoto T, Muraoka R, Satake N, Matsunaga T, Tsujino T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.
BMC Cancer. 2021 Feb 27;21(1):201.
PMID：33639880

・ Role of systemic inflammatory response markers in urological malignancy.
Ohno Y
Int J Urol. 2019 Jan;26(1):31-47.
PMID：30253448
・ Salvage radiation therapy for prostate cancer patients after prostatectomy.
Mima T, Ohori M, Hirasawa Y, Mikami R, Arai A, Hashimoto T, Satake N, Gondo T, Nakagami Y, Namiki K, Tokuuye K, Ohno Y
Jpn J Clin Oncol. 2019 Mar 1;49(3):281-286.
PMID：30608594
・ Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
Kamoda N, Ohori M, Hirasawa Y, Inoue R, Hashimoto T, Satake N, Gondo T, Nakagami Y, Nagao T, Ohno Y.
Jpn J Clin Oncol. 2019 Mar 1;49(3):276-280
PMID：30649377
・ C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan
Tsujino T, Komura K, Hashimoto T, Muraoka R, Satake N, Matsunaga T, Tsutsumi T, Yoshikawa Y, Takai T, Minami K, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.
Urol Oncol. 2019 Nov;37(11):812.e1-812.e8.
PMID：31053528
・ The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan
Komura K, Hashimoto T, Tsujino T, Muraoka R, Tsutsumi T, Satake N, Matsunaga T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Uehara H, Tanaka T, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.
Ann Surg Oncol. 2019 Sep;26(9):2994-3004.
PMID：31240592

・ Prostate-specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer.
Hashimoto T, Ohori M, Shimodaira K, Kaburaki N, Hirasawa Y, Satake N, Gondo T, Nakagami Y, Namiki K, Ohno Y.
Int J Urol. 2018 Apr 6. doi: 10.1111/iju.13563. [Epub ahead of print]　PMID:29633374
・ Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
Ohno Y.
Int J Urol. 2018 Mar;25(3):238-239. doi: 10.1111/iju.13506. Epub 2017 Dec 7. No abstract available.　 PMID:29216687
・ The Impact of Lateral Bladder Neck Preservation on Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy.
Hashimoto T, Yoshioka K, Gondo T, Hasama K, Hirasawa Y, Nakashima J, Tachibana M, Ohno Y.
J Endourol. 2018 Jan;32(1):40-45. doi: 10.1089/end.2017.0459. Epub 2017 Nov 3.　PMID:28978229
・ No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.
Hirasawa Y, Ohori M, Sugihara T, Hashimoto T, Satake N, Gondo T, Nakagami Y, Namiki K, Yoshioka K, Nakashima J, Tachibana M, Ohno Y.
Jpn J Clin Oncol. 2017 Nov 1;47(11):1083-1089. doi: 10.1093/jjco/hyx125.　PMID:28973504
・ Age and prostate volume are risk factors for transient urinary incontinence after transurethral enucleation with bipolar for benign prostatic hyperplasia.
Hirasawa Y, Kato Y, Fujita K.
Int J Urol. 2018 Jan;25(1):76-80. doi: 10.1111/iju.13472. Epub 2017 Oct 3.　PMID:28975723

・ Transurethral enucleation with bipolar (TUEB) for benign prostatic hyperplasia: two-year outcomes and the learning curve of a single surgeon's experience of 603 consecutive patients.
Hirasawa Y, Kato Y, Fujita K.
J Endourol. 2017 May 2. doi: 10.1089/end.2017.0092. [Epub ahead of print]　PMID:28462670
・ Impact of Surgeon and Hospital Volume on the Safety of Robot-Assisted Radical Prostatectomy: A Multi-Institutional Study Based on a National Database.
Hirasawa Y, Yoshioka K, Nasu Y, Yamamoto M, Hinotsu S, Takenaka A, Fujisawa M, Shiroki R, Tozawa K, Fukasawa S, Kashiwagi A, Tatsugami K, Tachibana M, Terachi T, Gotoh M; Japanese Society of Endourology..
Urol Int. 2017;98(3):334-342. doi: 10.1159/000460304. Epub 2017 Mar 3.PMID:28253500
・ Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
Hashimoto T, Nakashima J, Kashima T, Hirasawa Y, Shimodaira K, Gondo T, Nakagami Y, Namiki K, Horiguchi Y, Ohno Y, Ohori M, Tachibana M.
Int J Urol. 2017 Feb;24(2):111-116. doi: 10.1111/iju.13256. Epub 2016 Nov 22.PMID:27875859
・ Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
Gondo T, Ohno Y, Nakashima J, Hashimoto T, Nakagami Y, Tachibana M.
Int Urol Nephrol. 2017 Feb;49(2):233-238. doi: 10.1007/s11255-016-1462-1. Epub 2016 Nov 21.PMID:27873153

・ Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer.
Hashimoto T, Rahul K, Takeda T, Benfante N, Mulhall JP, Hricak H, Eastham JA, Vargas HA.
Urol Oncol. 2016 Sep 21. pii: S1078-1439(16)30167-3.
・ Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y, Nakashima J, Yunaiyama D, Sugihara T, Gondo T, Nakagami Y, Horiguchi Y, Ohno Y, Namiki K, Ohori M, Tokuuye K, Tachibana M.
Ann Surg Oncol. 2016 Oct 3. PMID: 27699608
・ A Case of Primary Small-Cell Carcinoma of the Bladder
Ono A, Hirasawa Y, Yamashina M, Kaburagi N, Mima T, Sugihara T, Hamada R, Gondo T, Ohori M, Nagao T, Ohno Y.
Case Reports in Oncology 9(3):574-579 ・ October 2016
・ [Clinical implication of PSA in the diagnosis of prostate cancer].
Nakashima J, Hirasawa Y, Kashima T, Shimodaira K, Sugihara T.
Nihon Rinsho. 2016 May 20;74 Suppl 3:295-9. Japanese. No abstract available. PMID:27344745
・ Development of a Nomogram for Predicting Severe Neutropenia Associated With Docetaxel-Based Chemotherapy in Patients With Castration-Resistant Prostate Cancer.
Hirasawa Y, Nakashima J, Sugihara T, Takizawa I, Gondo T, Nakagami Y, Horiguchi Y, Ohno Y, Namiki K, Ohori M, Tachibana M.
Clin Genitourin Cancer. 2016 May 27. pii: S1558-7673(16)30138-0. doi: 10.1016/j.clgc.2016.05.012
・ Da Vinci surgery for prostate cancer and bladder cancer in Japan
Hirasawa Y, Yoshioka K, Iseki R, Tachibana M.
The Japan Society of Computer Aided Surgery. 2014 January
DOI:10.5759/jscas.16.363
・ How will the robotic surgery develop in the future?
Hirasawa Y, Iseki R, Yoshioka K.
Japanese Journal of Urological Surgery: 2016.vol.29. 595-598
・ Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Accompanied by Dysuria.
Takeuchi H, Kuroda I, Takizawa I, Aoyagi T, Tachibana M.
Case Rep Urol. 2016;2016:7812875. doi: 10.1155/2016/7812875. Epub 2016 Mar 13. PMID:27034883

・ Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R, Nakashima J, Ohori M, Ohno Y, Komori O, Yoshioka K, Tachibana M.
Int J Clin Oncol. 2015 Nov 19. [Epub ahead of print] PMID:26585896
・ Impact of a preoperatively estimated prostate volume using transrectal ultrasonography on surgical and oncological outcomes in a single surgeon's experience with robot-assisted radical prostatectomy.
Hirasawa Y, Ohno Y, Nakashima J, Shimodaira K, Hashimoto T, Gondo T, Ohori M, Tachibana M, Yoshioka K.
Surg Endosc. 2015 Nov 17. [Epub ahead of print] PMID:26578435
・ Is scintigraphy necessary to detect migration of (125)I seeds after brachytherapy for early prostate cancer?
Odagaki Y, Ohori M, Yoshimura M, Nakshima J, Ohno Y, Mikami R, Nakayama H, Tokuuye K, Tachibana M.
Int J Clin Oncol. 2016 Apr;21(2):397-401. doi: 10.1007/s10147-015-0901-9. Epub 2015 Sep 22.
PMID:26394786
・ Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
Hashimoto T, Ohno Y, Nakashima J, Gondo T, Nakagami Y, Namiki K, Horiguchi Y, Yoshioka K, Ohori M, Tachibana M.
Jpn J Clin Oncol. 2015 Nov;45(11):1064-8. doi: 10.1093/jjco/hyv136. Epub 2015 Sep 9. PMID:26355160
・ Clinical effect of a positive surgical margin without extraprostatic extension after robot-assisted radical prostatectomy.
Hashimoto T, Yoshioka K, Horiguchi Y, Inoue R, Yoshio O, Nakashima J, Tachibana M.
Urol Oncol. 2015 Dec;33(12):503.e1-6. doi: 10.1016/j.urolonc.2015.07.009. Epub 2015 Aug 12.
PMID:26277617
・ Associations between ABO blood groups and biochemical recurrence after radical prostatectomy.
Ohno Y, Ohori M, Nakashima J, Okubo H, Satake N, Takizawa I, Hashimoto T, Hamada R, Nakagami Y, Yoshioka K, Tachibana M.
Int J Clin Exp Med. 2015 Feb 15;8(2):2642-8. eCollection 2015. PMID:25932213
・ Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer.
Satake N, Ohno Y, Nakashima J, Ohori M, Tachibana M.
Int J Urol. 2015 Jul;22(7):645-9. doi: 10.1111/iju.12788. Epub 2015 Apr 24. PMID:25912166

・ [Robot-assisted surgery-the current state of radical prostatectomy].
Hashimoto T, Yoshioka K, Namiki K, Ohno Y, Tachibana M.
Gan To Kagaku Ryoho. 2014 Nov;41(11):1340-8. Review. Japanese. PMID:25434435
・ Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
Hashimoto T, Yoshioka K, Nagao G, Nakagami Y, Ohno Y, Horiguchi Y, Namiki K, Nakashima J, Tachibana M.
Int J Urol. 2015 Feb;22(2):188-93. doi: 10.1111/iju.12624. Epub 2014 Oct 22. PMID:25339062
・ Prediction of multifocal lesions in patients with upper tract urothelial carcinoma.
Hashimoto T, Ohno Y, Nakashima J, Gondo T, Yoshioka K, Ohori M, Tachibana M.
Urology. 2014 Oct;84(4):869-74. doi: 10.1016/j.urology.2014.05.041. Epub 2014 Aug 6. PMID:25106945
・ Prediction of non-biochemical recurrence rate after radical prostatectomy in a Japanese cohort: development of a postoperative nomogram.
Okubo H, Ohori M, Ohno Y, Nakashima J, Inoue R, Nagao T, Tachibana M.
Int J Urol. 2014 May;21(5):479-83.

・ Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer.
Gondo T, Ohno Y, Nakashima J, Hashimoto T, Takizawa I, Tanaka A, Shimodaira K, Satake N, Takeuchi H, Nakagami Y, Ohori M, Tachibana M.
Int J Clin Oncol. 2013 Dec 11. [Epub ahead of print]
・ Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma.
Ohno Y, Nakashima J, Nakagami Y, Gondo T, Ohori M, Hatano T, Tachibana M.
Urology. 2014 Jan;83(1):154-8. doi: 10.1016/j.urology.2013.08.052. Epub 2013 Oct 19.
・ External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.
Tanaka A, Ohori M, Paul L, Yu C, Kattan MW, Ohno Y, Tachibana M.
Jpn J Clin Oncol. 2013 Dec;43(12):1255-60. doi: 10.1093/jjco/hyt154.
・ Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan.
Hashimoto T, Yoshioka K, Gondo T, Ozu C, Horiguchi Y, Namiki K, Ohno Y, Ohori M, Nakashima J, Tachibana M.
Int J Clin Oncol. 2013 Sep 19. [Epub ahead of print]
・ Learning curve and perioperative outcomes of robot-assisted radical prostatectomy in 200 initial Japanese cases by a single surgeon.
Hashimoto T, Yoshioka K, Gondo T, Kamoda N, Satake N, Ozu C, Horiguchi Y, Namiki K, Nakashima J, Tachibana M.
J Endourol. 2013 Oct;27(10):1218-23. doi: 10.1089/end.2013.0235. Epub 2013 Sep 14.
・ Chemical cystitis due to crystal violet dye: a case report.
Hashimoto T, Ohori M, Kashima T, Yamamoto H, Tachibana M.
J Med Case Rep. 2013 May 31;7(1):145. doi: 10.1186/1752- 1947-7-145.
・ Torsion of a seminoma in an intrascrotal testis: A case report and review of the literature.
Gondo T, Namiki K, Tanaka A, Yoshioka K, Tanaka M, Yamamoto H, Tachibana M.
Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E108-11. doi: 10.5489/cuaj.248.
・ Urethral condyloma acuminata in an elderly patient : a case report].
Tanaka A, Gondo T, Hashimoto T, Kashima T, Yamamoto H, Tanaka M, Ohno Y, Tachibana M.
Hinyokika Kiyo. 2013 Feb;59(2):133-5. Japanese.
・ Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma.
Hashimoto T, Nakashima J, Inoue R, Gondo T, Ohno Y, Tachibana M.
Int J Clin Oncol. 2014 Apr;19(2):373-8. doi: 10.1007/s10147-013-0548-3. Epub 2013 Apr 3.
・ Predictors for positive surgical margins after robot-assisted radical prostatectomy: a single surgeon's series in Japan.
Hashimoto T, Yoshioka K, Gondo T, Takeuchi H, Nakagami Y, Nakashima J, Tachibana M.
Int J Urol. 2013 Sep;20(9):873-8. doi: 10.1111/iju.12081. Epub 2013 Feb 19.
・ Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-tolymphocyte ratio and performance status.
Ohno Y, Nakashima J, Ohori M, Tanaka A, Hashimoto T, Gondo T, Hatano T, Tachibana M.
Int J Clin Oncol. 2014 Feb;19(1):139-45. doi: 10.1007/s10147-012-0514-5. Epub 2013 Jan 9.
・ Decrease rate of the renal diameter in chronic hemodialysis patients.
Aoyagi T, Tachibana M, Naganuma S.
ISRN Nephrol. 2013 May 22;2013:521949. doi: 10.5402/2013/521949. eCollection 2013.

・ Emphysematous cystitis following a transrectal needle guided biopsy of the prostate.
Hashimoto T, Namiki K, Tanaka A, Shimodaira K, Gondo T, Tachibana M.
BMC Infect Dis. 2012 Nov 26;12:322. doi: 10.1186/1471-2334-12-322.
・ Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness.
Ohno Y, Nakashima J, Izumi M, Ohori M, Hashimoto T, Tachibana M.
World J Urol. 2013 Apr;31(2):359-64. doi: 10.1007/s00345-012-0977-z. Epub 2012 Nov 3.
・ Preoperative prediction of malignant involvement of resected ureters in patients undergoing radical cystectomy for bladder cancer.
Gondo T, Nakashima J, Ohno Y, Hashimoto T, Takizawa I, Sakamoto N, Horiguchi Y, Aoyagi T, Ohori M, Tachibana M.
Int J Urol. 2013 May;20(5):501-6. doi: 10.1111/j.1442-2042.2012.03203.x. Epub 2012 Oct 29.
・ Urinary incontinence in early experience with robot-assisted laparoscopic prostatectomy-comparison with radical retropubic prostatectomy].
Iseki R, Ohori M, Hatano T, Tachibana M.
Hinyokika Kiyo. 2012 Aug;58(8):409-14. Japanese.
・ Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma.
Hashimoto T, Ohno Y, Nakashima J, Gondo T, Ohori M, Tachibana M.
World J Urol. 2013 Aug;31(4):953-8. doi: 10.1007/s00345-012-0942-x. Epub 2012 Sep 13.
・ Pneumatosis intestinalis and hepatic portal venous gas in a patient receiving sorafenib.
Kashima T, Ohno Y, Tachibana M.
Int J Urol. 2012 Nov;19(11):1041-2. doi: 10.1111/j.1442-2042.2012.03099.x. Epub 2012 Jul 13.
・ Robotic versus open radical cystectomy: prospective comparison of perioperative and pathologic outcomes in Japan.
Gondo T, Yoshioka K, Nakagami Y, Okubo H, Hashimoto T, Satake N, Ozu C, Horiguchi Y, Namiki K, Tachibana M.
Jpn J Clin Oncol. 2012 Jul;42(7):625-31. doi: 10.1093/jjco/hys062. Epub 2012 May 11.
・ The powerful impact of double-layered posterior rhabdosphincter reconstruction on early recovery of urinary continence after robot-assisted radical prostatectomy.
Gondo T, Yoshioka K, Hashimoto T, Nakagami Y, Hamada R, Kashima T, Shimodaira K, Takeuchi H, Satake N,
Tachibana M, Rocco B. J Endourol. 2012 Sep;26(9):1159-64. doi: 10.1089/end.2012.0067. Epub 2012 Jun 25.
・ A case of plasmacytoid urothelial carcinoma of the bladder: rapid progression after transurethral resection].
Tanaka A, Ohori M, Hashimoto T, Hamada R, Nomura M, Kusama H, Nagao T, Tachibana M.
Hinyokika Kiyo. 2012 Feb;58(2):101-3. Japanese.
・ Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.
Urology. 2012 May;79(5):1085-91. doi: 10.1016/j.urology.2011.11.070. Epub 2012 Mar 23.

・ NF-kappaB inhibitor].
Nakashima J, Horiguchi Y, Ohno Y, Gondo T, Takeuchi H, Tachibana M.
Nihon Rinsho. 2011 Jun;69 Suppl 5:160-4. Review. Japanese.
・ Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma.
Ohno Y, Nakashima J, Ohori M, Gondo T, Hatano T, Tachibana M.
J Urol. 2012 Feb;187(2):411-7. doi: 10.1016/j.juro.2011.10.026. Epub 2011 Dec 15.
・ Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy.
Gondo T, Nakashima J, Ozu C, Ohno Y, Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.
Int J Clin Oncol. 2012 Oct;17(5):456-61. doi: 10.1007/s10147-011-0310-7. Epub 2011 Sep 7.
・ A rare case of an intra-abdominal flat desmoid tumor causing ureteral obstruction.
Gondo T, Yoshioka K, Tachibana M.
Int J Urol. 2011 Nov;18(11):803-4. doi: 10.1111/j.1442-2042.2011.02844.x. Epub 2011 Sep 4.